These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 3925068

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cyclosporine potentiates the immunosuppressive effects of anti-interleukin 2 receptor monoclonal antibody therapy.
    Kupiec-Weglinski JW, Hahn HJ, Kirkman RL, Volk HD, Mouzaki A, DiStefano R, Tellides G, Dallman M, Morris PJ, Strom TB.
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):207-16. PubMed ID: 3129841
    [No Abstract] [Full Text] [Related]

  • 5. Prolongation of murine skin allograft survival by immunologic manipulation with anti-interleukin 2 receptor antibody.
    Granstein RD, Goulston C, Gaulton GN.
    J Immunol; 1986 Feb 01; 136(3):898-902. PubMed ID: 3079802
    [Abstract] [Full Text] [Related]

  • 6. Therapy with monoclonal antibody to interleukin 2 receptor spares suppressor T cells and prevents or reverses acute allograft rejection in rats.
    Kupiec-Weglinski JW, Diamantstein T, Tilney NL, Strom TB.
    Proc Natl Acad Sci U S A; 1986 Apr 01; 83(8):2624-7. PubMed ID: 2939456
    [Abstract] [Full Text] [Related]

  • 7. Specific immunosuppressive therapy by monoclonal anti-IL 2 receptor antibody and its synergistic action with cyclosporin.
    Diamantstein T, Volk HD, Tilney NL, Kupiec-Weglinski J.
    Immunobiology; 1986 Sep 01; 172(3-5):391-9. PubMed ID: 3100433
    [Abstract] [Full Text] [Related]

  • 8. Anti-Tac-H, a humanized antibody to the interleukin 2 receptor, prolongs primate cardiac allograft survival.
    Brown PS, Parenteau GL, Dirbas FM, Garsia RJ, Goldman CK, Bukowski MA, Junghans RP, Queen C, Hakimi J, Benjamin WR.
    Proc Natl Acad Sci U S A; 1991 Apr 01; 88(7):2663-7. PubMed ID: 2011577
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Selective immunosuppression with anti-interleukin 2 receptor-targeted therapy: helper and suppressor cell activity in rat recipients of cardiac allografts.
    Kupiec-Weglinski JW, Padberg W, Uhteg LC, Ma L, Lord RH, Araneda D, Strom TB, Diamantstein T, Tilney NL.
    Eur J Immunol; 1987 Mar 01; 17(3):313-9. PubMed ID: 2952511
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Anti-interleukin 2 receptor monoclonal antibody therapy in rat recipients of cardiac allografts: the role of antibody isotype.
    Kupiec-Weglinski JW, Di Stefano R, Stunkel KG, Grutzmann R, Theisen P, Araneda D, Tilney NL, Diamantstein T.
    Transplant Proc; 1988 Feb 01; 20(1 Suppl 1):272-5. PubMed ID: 3126574
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Humanized antibody directed to the IL-2 receptor beta-chain prolongs primate cardiac allograft survival.
    Tinubu SA, Hakimi J, Kondas JA, Bailon P, Familletti PC, Spence C, Crittenden MD, Parenteau GL, Dirbas FM, Tsudo M.
    J Immunol; 1994 Nov 01; 153(9):4330-8. PubMed ID: 7930631
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Interleukin-10 eliminates anti-CD3 monoclonal antibody-induced mortality and prolongs heart allograft survival in inbred mice.
    Lowry RP, Konieczny B, Alexander D, Larsen C, Pearson T, Smith S, Narula S.
    Transplant Proc; 1995 Feb 01; 27(1):392-4. PubMed ID: 7879034
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.